Ignite Creation Date:
2024-05-06 @ 2:05 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04205903
Status:
RECRUITING
Last Update Posted:
2023-02-27
First Post:
2019-06-18
Brief Title:
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Ohio State University Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-01-02
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-18
First Submit QC Date:
December 17 2019
Study First Post Date:
2019-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-24
Last Update Post Date:
2023-02-27
Last Update Post Date Type:
ACTUAL